European Multicenter Evaluation of Xpert® Xpress SARS-CoV-2/Flu/RSV Test

Overview

Journal J Med Virol

Specialty Microbiology

Date 2021 May 29

PMID 34050951

Citations 18

Authors

Femke Wolters

Maria Grunberg

Michael Huber

Harald H Kessler

Florian Pruller

Lanja Saleh

Christine Febreau

Janette Rahamat-Langendoen

Vincent Thibault

Willem J G Melchers

Affiliations

Soon will be listed here.

Abstract

Rapid diagnostics for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are paramount for reducing the spread of the current pandemic. During additional seasonal epidemics with influenza A/B and respiratory syncytial virus (RSV), the clinical signs and symptoms cannot be distinguished easily from SARS-CoV-2. Therefore, a new assay combining four targets in the form of the new Xpert Xpress SARS-CoV-2/Flu/RSV assay was evaluated. The assay was compared to the Xpert Xpress SARS-CoV-2, Xpert Xpress Flu/RSV, Seegene Flu/RSV, influenza A/B r-gene® and RSV/hMPV r-gene®. A total of 295 nasopharyngeal and throat swabs were tested at four institutes throughout Europe including 72 samples positive for SARS-CoV-2, 65 for influenza A, 47 for influenza B, and 77 for RSV. The sensitivity of the new assay was above 95% for all targets, with the highest for SARS-CoV-2 (97.2%). The overall correlation of SARS-CoV-2 Ct values between Xpert Xpress SARS-CoV-2 assay and Xpert Xpress SARS-CoV-2/Flu/RSV assay was high. The agreement between Ct values above 30 showed the multiplex giving higher Ct values for SARS-CoV-2 on average than the singleplex assay. In conclusion, the new assay is a rapid and reliable alternative with less hands-on time for the detection of not one, but four upper respiratory tract pathogens that may circulate at the same time.

Citing Articles

Key Insights into Respiratory Virus Testing: Sensitivity and Clinical Implications.

Garcia-Rodriguez J, Janvier F, Kill C Microorganisms. 2025; 13(1).

PMID: 39858831 PMC: 11767719. DOI: 10.3390/microorganisms13010063.

Key performance evaluation of commercialized multiplex rRT-PCR kits for respiratory viruses: implications for application and optimization.

Feng W, Chen Y, Han Y, Diao Z, Zhao Z, Zhang Y Microbiol Spectr. 2024; :e0164124.

PMID: 39470276 PMC: 11619282. DOI: 10.1128/spectrum.01641-24.

Characterization of viral infections in children with influenza-like-illness during December 2018-January 2019.

Chao S, Wang Y, Wu B, Li R, Dong J, Ji L Front Cell Infect Microbiol. 2024; 13:1351814.

PMID: 38304460 PMC: 10830827. DOI: 10.3389/fcimb.2023.1351814.

One assay to test them all: Multiplex assays for expansion of respiratory virus surveillance.

Boukli N, Flamand C, Chea K, Heng L, Keo S, Sour K Front Med (Lausanne). 2023; 10:1161268.

PMID: 37168265 PMC: 10165998. DOI: 10.3389/fmed.2023.1161268.

Gargle sample is an effective option in a novel fully automated molecular point-of-care test for influenza: a multicenter study.

Kaku N, Urabe T, Iida T, Yun C, Nishida Y, Onitsuka Y Virol J. 2023; 20(1):41.

PMID: 36869389 PMC: 9983540. DOI: 10.1186/s12985-023-01993-5.

References

Wolters F, van de Bovenkamp J, van den Bosch B, van den Brink S, Broeders M, Chung N . Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic. J Clin Virol. 2020; 128:104426. PMC: 7211760. DOI: 10.1016/j.jcv.2020.104426. View

Volz E, Hill V, McCrone J, Price A, Jorgensen D, OToole A . Evaluating the Effects of SARS-CoV-2 Spike Mutation D614G on Transmissibility and Pathogenicity. Cell. 2020; 184(1):64-75.e11. PMC: 7674007. DOI: 10.1016/j.cell.2020.11.020. View

Korber B, Fischer W, Gnanakaran S, Yoon H, Theiler J, Abfalterer W . Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus. Cell. 2020; 182(4):812-827.e19. PMC: 7332439. DOI: 10.1016/j.cell.2020.06.043. View

Sullivan S, Carlson S, Cheng A, Chilver M, Dwyer D, Irwin M . Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020. Euro Surveill. 2020; 25(47). PMC: 7693168. DOI: 10.2807/1560-7917.ES.2020.25.47.2001847. View

Ellis S, Coffey C, Mitchel Jr E, Dittus R, Griffin M . Influenza- and respiratory syncytial virus-associated morbidity and mortality in the nursing home population. J Am Geriatr Soc. 2003; 51(6):761-7. PMC: 7159134. DOI: 10.1046/j.1365-2389.2003.51254.x. View

Abanses J, Dowd M, Simon S, Sharma V . Impact of rapid influenza testing at triage on management of febrile infants and young children. Pediatr Emerg Care. 2006; 22(3):145-9. DOI: 10.1097/01.pec.0000202454.19237.b0. View

Fleming D, Pannell R, Cross K . Mortality in children from influenza and respiratory syncytial virus. J Epidemiol Community Health. 2005; 59(7):586-90. PMC: 1757088. DOI: 10.1136/jech.2004.026450. View

Kong W, Li Y, Peng M, Kong D, Yang X, Wang L . SARS-CoV-2 detection in patients with influenza-like illness. Nat Microbiol. 2020; 5(5):675-678. DOI: 10.1038/s41564-020-0713-1. View

Bloom-Feshbach K, Alonso W, Charu V, Tamerius J, Simonsen L, Miller M . Latitudinal variations in seasonal activity of influenza and respiratory syncytial virus (RSV): a global comparative review. PLoS One. 2013; 8(2):e54445. PMC: 3573019. DOI: 10.1371/journal.pone.0054445. View

10.

Wolters F, Grunberg M, Huber M, Kessler H, Pruller F, Saleh L . European multicenter evaluation of Xpert® Xpress SARS-CoV-2/Flu/RSV test. J Med Virol. 2021; 93(10):5798-5804. PMC: 8242864. DOI: 10.1002/jmv.27111. View

11.

Hu A, Colella M, Tam J, Rappaport R, Cheng S . Simultaneous detection, subgrouping, and quantitation of respiratory syncytial virus A and B by real-time PCR. J Clin Microbiol. 2003; 41(1):149-54. PMC: 149607. DOI: 10.1128/JCM.41.1.149-154.2003. View

12.

Cohen D, Kline J, May L, Harnett G, Gibson J, Liang S . Accurate PCR Detection of Influenza A/B and Respiratory Syncytial Viruses by Use of Cepheid Xpert Flu+RSV Xpress Assay in Point-of-Care Settings: Comparison to Prodesse ProFlu. J Clin Microbiol. 2017; 56(2). PMC: 5786727. DOI: 10.1128/JCM.01237-17. View

13.

Corman V, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu D . Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020; 25(3). PMC: 6988269. DOI: 10.2807/1560-7917.ES.2020.25.3.2000045. View

14.

Cuadrado-Payan E, Montagud-Marrahi E, Torres-Elorza M, Bodro M, Blasco M, Poch E . SARS-CoV-2 and influenza virus co-infection. Lancet. 2020; 395(10236):e84. PMC: 7200126. DOI: 10.1016/S0140-6736(20)31052-7. View

15.

Alm E, Broberg E, Connor T, Hodcroft E, Komissarov A, Maurer-Stroh S . Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020. Euro Surveill. 2020; 25(32). PMC: 7427299. DOI: 10.2807/1560-7917.ES.2020.25.32.2001410. View

16.

Kwon Y, Park S, Kim M, Kim H, Park J, Lee M . Risk of mortality associated with respiratory syncytial virus and influenza infection in adults. BMC Infect Dis. 2017; 17(1):785. PMC: 5738863. DOI: 10.1186/s12879-017-2897-4. View

17.

Loeffelholz M, Alland D, Butler-Wu S, Pandey U, Perno C, Nava A . Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test. J Clin Microbiol. 2020; 58(8). PMC: 7383535. DOI: 10.1128/JCM.00926-20. View

18.

Fleming D, Elliot A, Cross K . Morbidity profiles of patients consulting during influenza and respiratory syncytial virus active periods. Epidemiol Infect. 2007; 135(7):1099-108. PMC: 2870675. DOI: 10.1017/S0950268807007881. View

19.

Salez N, Nougairede A, Ninove L, Zandotti C, de Lamballerie X, Charrel R . Prospective and retrospective evaluation of the Cepheid Xpert® Flu/RSV XC assay for rapid detection of influenza A, influenza B, and respiratory syncytial virus. Diagn Microbiol Infect Dis. 2015; 81(4):256-8. PMC: 7172894. DOI: 10.1016/j.diagmicrobio.2015.01.008. View